Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.

Details

Ressource 1Download: 39485845.pdf (20978.65 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_20718CBE7864
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.
Journal
Science advances
Author(s)
Sokratian A., Zhou Y., Tatli M., Burbidge K.J., Xu E., Viverette E., Donzelli S., Duda A.M., Yuan Y., Li H., Strader S., Patel N., Shiell L., Malankhanova T., Chen O., Mazzulli J.R., Perera L., Stahlberg H., Borgnia M., Bartesaghi A., Lashuel H.A., West A.B.
ISSN
2375-2548 (Electronic)
ISSN-L
2375-2548
Publication state
Published
Issued date
11/2024
Peer-reviewed
Oui
Volume
10
Number
44
Pages
eadq3539
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
The intricate process of α-synuclein aggregation and fibrillization holds pivotal roles in Parkinson's disease (PD) and multiple system atrophy (MSA). While mouse α-synuclein can fibrillize in vitro, whether these fibrils commonly used in research to induce this process or form can reproduce structures in the human brain remains unknown. Here, we report the first atomic structure of mouse α-synuclein fibrils, which was solved in parallel by two independent teams. The structure shows striking similarity to MSA-amplified and PD-associated E46K fibrils. However, mouse α-synuclein fibrils display altered packing arrangements, reduced hydrophobicity, and heightened fragmentation sensitivity and evoke only weak immunological responses. Furthermore, mouse α-synuclein fibrils exhibit exacerbated pathological spread in neurons and humanized α-synuclein mice. These findings provide critical insights into the structural underpinnings of α-synuclein pathogenicity and emphasize a need to reassess the role of mouse α-synuclein fibrils in the development of related diagnostic probes and therapeutic interventions.
Keywords
alpha-Synuclein/metabolism, alpha-Synuclein/chemistry, Humans, Animals, Mice, Lewy Body Disease/metabolism, Lewy Body Disease/pathology, Parkinson Disease/metabolism, Parkinson Disease/pathology, Amyloid/metabolism, Amyloid/chemistry, Mice, Transgenic, Models, Molecular, Multiple System Atrophy/metabolism, Multiple System Atrophy/pathology, Disease Models, Animal, Neurons/metabolism, Neurons/pathology, Brain/metabolism, Brain/pathology
Pubmed
Open Access
Yes
Create date
11/11/2024 15:47
Last modification date
12/11/2024 7:09
Usage data